Talk to Sam

+1 917 267 7886

data types

Erythropoietin Market and Forecasts, May 2013

You might be interested in: protein, anemia, biosimilar, more »


 
1-10 of about 100 reports for Erythropoietin
Biopharmaceutical Sector Brief

Biopharmaceutical Sector Brief

  • Industry report
  • July 2012
  • 16 pages

... Inc. Preclinical epor agonist source: gbi research; clinicaltrials.Gov; company websites pipeline as of march 2012 epor: erythropoietin receptor gbihc228mr / published jul 2012 page 76 ...

Anemia Market Brief

Anemia Market Brief

  • Industry report
  • June 2012
  • 12 pages

... Rapidly ensues unless individuals are iron-overloaded from prior transfusions. Therefore, iron therapy is essential when using erythropoietin to maximize erythropoiesis by avoiding absolute ...

Syringe Market Brief

Syringe Market Brief

  • Industry report
  • March 2011
  • 11 pages

... Production. erythropoietin receptors may be expressed on the surface of a variety of tumour cells. As with all growth factors, there is a concern that esas could stimulate the growth of any type ...

Blood Cell Market Brief

Blood Cell Market Brief

  • Industry report
  • August 2012
  • 3 pages
  • by Governmental Agency

... And morbidities independent of the primary disease. For patients with low erythropoietin levels relative to the degree of anaemia, erythropoietin may increase haemoglobin sufficiently; otherwise, red blood cell ...

The Indian Protein Market : Market Overview and Key Players (protein, recombinant protein)

The Indian Protein Market : Market Overview and Key Players (protein, recombinant protein)

  • Industry report
  • October 2012
  • 6 pages

... Is a vegetative propagated plant, which minimizes the spread of transgene contamination through pollen, and high tuber bio- mass makes it suitable for bulk production8. erythropoietin (epo) was chosen as a protein ...

Blood Supply Sector  in The United States and The United Kingdom

Blood Supply Sector in The United States and The United Kingdom

  • Industry report
  • December 2011
  • 9 pages

... Complicated interventions, such as erythropoietin and preoperative autologous donation. Simple measures include those that aim to increase the patient S haemoglobin concentration. This is most applicable ...

Biosimilar Business  in Iran and South Korea

Biosimilar Business in Iran and South Korea

  • Industry report
  • May 2012
  • 8 pages

... As an example according to a published report, among several recombinant erythropoietins manufactured in asia none was comparable with the originator product from structural point of view [11]. However ...

The Japanese Drug and Medication Industry Brief

The Japanese Drug and Medication Industry Brief

  • Industry report
  • April 2011
  • 18 pages

... Anticancer 1537 pravastatin hypolipidaemic 2266 oxycodone analgesic 1529 erythropoietin antianaemic 2260 azithromycin ...

Clinical Trial in Canada and The United States : Innovation and Technology Trends

Clinical Trial in Canada and The United States : Innovation and Technology Trends

  • Industry report
  • April 2012
  • 27 pages

... In countries with emerging economies attractive preclinical studies Cyclosporine mazzeo 2009 erythropoietine yatsiv 2005, zhang 2009 Progesterone xiao 2008 Statins tapia-perez 2008 Vit d and ...

U.S. Generic Drug Industry : Innovation and Technology Trends

U.S. Generic Drug Industry : Innovation and Technology Trends

  • Industry report
  • July 2012
  • 24 pages

... The way in the biosimilars market with xx approved biosimilars belonging to the erythropoietin (epo) and granulocyte colony stimulating factors (g-csf) and human growth hormones (hgh) groups ...

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.